The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia

Abstract Nias Island, off the north-western coast of Sumatra, Indonesia, was one of the first locations in which chloroquine-resistant Plasmodium vivax malaria was reported. This resistance is of particular concern because its ancient megalithic culture and the outstanding surfing conditions make the island a popular tourist destination. International travel to and from the island could rapidly spread chloroquine-resistant strains of P. vivax across the planet. The threat posed by such strains, locally and internationally, has led to the routine and periodic re-assessment of the efficacy of antimalarial drugs and transmission potential on the island. Active case detection identified malaria in 124 (17%) of 710 local residents whereas passive case detection, at the central health clinic, confirmed malaria in 77 (44%) of 173 cases of presumed 'clinical malaria'. Informed consenting volunteers who had malarial parasitaemias were treated, according to the Indonesian Ministry of Health's recommendations, with sulfadoxine-pyrimethamine (SP) on day 0 (for P. falciparum) or with chloroquine (CQ) on days 0, 1 and 2 (for P. vivax). Each volunteer was then monitored for clinical and parasite response until day 28. Recurrent parasitaemia by day 28 treatment was seen in 29 (83%) of the 35 P. falciparum cases given SP (14, 11 and four cases showing RI, RII and RIII resistance, respectively). Recurrent parasitaemia was also observed, between day 11 and day 21, in six (21%) of the 28 P. vivax cases given CQ. Although the results of quantitative analysis confirmed only low prevalences of CQ-resistant P. vivax malaria, the prevalence of SP resistance among the P. falciparum cases was among the highest seen in Indonesia. When the parasites present in the volunteers with P. falciparum infections were genotyped, mutations associated with pyrimethamine resistance were found at high frequency in the dhfr gene but there was no evidence of selection for sulfadoxine resistance in the dhps gene. Night-biting mosquitoes were surveyed by human landing collections and tested for sporozoite infection. Among the five species of human-biting anophelines collected, Anopheles sundaicus was dominant (68%) and the only species found to be infective—two (1.2%) of 167 females being found carrying P. vivax sporozoites. The risk of malarial infection for humans on Nias was considered high because of the abundance of asymptomatic carriers, the reduced effectiveness of the available antimalarial drugs, and the biting and infection 'rates' of the local An. sundaicus.

[1]  Nirbhay Kumar,et al.  Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu onPlasmodium falciparum , 2004, Parasitology Research.

[2]  K. Vick Aid group: Malaria drug need is ignored. Africans still rely on inferior therapy. , 2002 .

[3]  P. Winstanley,et al.  Modern chemotherapeutic options for malaria. , 2001, The Lancet. Infectious diseases.

[4]  J. Wootton,et al.  Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. , 2001, The Journal of infectious diseases.

[5]  J. Carlton,et al.  Of mice and malaria mutants: unravelling the genetics of drug resistance using rodent malaria models. , 2001, Trends in parasitology.

[6]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[7]  U. Hwang,et al.  Daily survival and human blood index of Anopheles sinensis, the vector species of malaria in Korea. , 2001, Journal of the American Mosquito Control Association.

[8]  X. Su,et al.  A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[9]  D. Warhurst A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[10]  S. Nagappan,et al.  Short report: differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia. , 2001, The American journal of tropical medicine and hygiene.

[11]  J. Trape,et al.  Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. , 2000, The American journal of tropical medicine and hygiene.

[12]  J. Baird,et al.  Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. , 1998, The American journal of tropical medicine and hygiene.

[13]  T. Ouatas,et al.  Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. , 1998, Molecular and biochemical parasitology.

[14]  M. Duraisingh,et al.  Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. , 1998, Experimental parasitology.

[15]  P. Somboon,et al.  Comparative susceptibility of two forms of Anopheles sinensis Wiedemann 1828 (Diptera : Culicidae) to infection with Plasmodium falciparum, P. vivax, P. yoelii and the determination of misleading factor for sporozoite identification. , 1998, The Southeast Asian journal of tropical medicine and public health.

[16]  C. Mendis,et al.  The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. , 1998, The American journal of tropical medicine and hygiene.

[17]  J. E. Hyde,et al.  Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. , 1997, Molecular and biochemical parasitology.

[18]  G. Butcher Antimalarial drugs and the mosquito transmission of Plasmodium. , 1997, International journal for parasitology.

[19]  J. E. Hyde,et al.  Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization , 1997, Molecular microbiology.

[20]  K. Kain,et al.  Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. , 1996, The Journal of infectious diseases.

[21]  R. Price,et al.  Effects of artemisinin derivatives on malaria transmissibility , 1996, The Lancet.

[22]  N. Kshirsagar,et al.  Vivax malaria resistant to chloroquine: case reports from Bombay. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  J. Lines,et al.  Susceptibility of Thai zoophilic Anophelines and suspected malaria vectors to local strains of human malaria parasites. , 1994, The Southeast Asian journal of tropical medicine and public health.

[24]  C. Mendis,et al.  Infectivity of Plasmodium vivax and P. falciparum to Anopheles tessellatus; relationship between oocyst and sporozoite development. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  T. Burkot,et al.  Development and evaluation of an enzyme-linked immunosorbent assay for Plasmodium vivax-VK247 sporozoites. , 1992, Journal of medical entomology.

[26]  W. Collins,et al.  The susceptibility of the Indonesian I/CDC strain of Plasmodium vivax to chloroquine. , 1992, The Journal of parasitology.

[27]  W. Maier,et al.  Plasmodium falciparum: effect of chloroquine, halofantrine and pyrimethamine on the infectivity of gametocytes for Anopheles stephensi mosquitoes. , 1992, Annals of tropical medicine and parasitology.

[28]  W. Schwartz,et al.  Hospital cost containment in the 1980s. Hard lessons learned and prospects for the 1990s. , 1991, The New England journal of medicine.

[29]  K. Rieckmann,et al.  PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE? , 1989, The Lancet.

[30]  A. Kaneko,et al.  Chemotherapeutic malaria control operation by single dose of Fansidar plus primaquine in North Sumatra, Indonesia. , 1989, The Southeast Asian journal of tropical medicine and public health.

[31]  Chobei Imai,et al.  北スマトラの 1 海岸村落における Anopheles sundaicus 幼虫の生態学的研究 : I. 地形, 土地利用および幼虫の発生 , 1988 .

[32]  S. Hoffman,et al.  Pyrimethamine-sulfadoxine still effective against Plasmodium falciparum in Jayapura, Irian Jaya: RI-type resistance in 2 of 18 patients. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  G. Strickland,et al.  Effects of Fansidar on chloroquine-resistant Plasmodium falciparum in Pakistan. , 1986, The American journal of tropical medicine and hygiene.

[34]  S. Hoffman,et al.  RII AND RIII TYPE RESISTANCE OF PLASMODIUM FALCIPARUM TO COMBINATION OF MEFLOQUINE AND SULFADOXINE/PYRIMETHAMINE IN INDONESIA , 1985, The Lancet.

[35]  T. Burkot,et al.  Identification of Plasmodium vivax sporozoites in mosquitoes using an enzyme-linked immunosorbent assay. , 1985, The American journal of tropical medicine and hygiene.

[36]  A. Ittiravivongs,et al.  The effect of sulphadoxine/pyrimethamine on gametocytes in falciparum malaria. , 1984, The Southeast Asian journal of tropical medicine and public health.

[37]  F. Churchill,et al.  Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. , 1983, Journal of chromatography.

[38]  J. Meuwissen THE USE OF MEDICATED SALT IN AN ANTIMALARIA CAMPAIGN IN WEST NEW GUINEA. , 1964, Tropical and geographical medicine.

[39]  J. Meuwissen Resistance of Plasmodium falciparum to pyrimethamine and proguanil in Netherlands New Guinea. , 1961, The American journal of tropical medicine and hygiene.

[40]  R. Bray Resistance of Plasmodium falciparum to pyrimethamine , 1955 .